These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8187662)

  • 21. Pharmacokinetics of albendazole in man.
    Marriner SE; Morris DL; Dickson B; Bogan JA
    Eur J Clin Pharmacol; 1986; 30(6):705-8. PubMed ID: 3770064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease.
    Mohamed AE; Yasawy MI; Al Karawi MA
    Hepatogastroenterology; 1998; 45(23):1690-4. PubMed ID: 9840130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.
    Capan M; Keltner S; Thalhammer F; Winkler S; Jäger W; Zeitlinger M; Ramharter M
    Am J Trop Med Hyg; 2009 Oct; 81(4):712-3. PubMed ID: 19815892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.
    Sanyal PK
    Vet Res Commun; 1998 Feb; 22(2):87-96. PubMed ID: 9563167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of concentration of albendazole sulfoxide in plasma and uterine fluid of heifers.
    Piscopo SE; Farin CE; Bai SA
    Am J Vet Res; 1997 Jan; 58(1):62-5. PubMed ID: 8989498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations.
    Na-Bangchang K; Kietinun S; Pawa KK; Hanpitakpong W; Na-Bangchang C; Lazdins J
    Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):335-45. PubMed ID: 16271272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
    Capece BP; Castells G; Pérez F; Arboix M; Cristòfol C
    Vet Res Commun; 2000 Jul; 24(5):339-48. PubMed ID: 10868551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
    Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
    Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase.
    Paias FO; Lanchote VL; Takayanagui OM; Bonato PS
    Chirality; 1997; 9(8):722-6. PubMed ID: 9435097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative determination of albendazole and its main metabolites in plasma.
    Garcia JJ; Bolás-Fernández F; Torrado JJ
    J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):265-71. PubMed ID: 10080654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?
    Domínguez L; Savio E; Saldaña J; Malanga A; Quevedo D; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Nov; 137(10):383-6. PubMed ID: 9880943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats.
    Benoit E; Besse S; Delatour P
    Am J Vet Res; 1992 Sep; 53(9):1663-5. PubMed ID: 1416373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
    Delatour P; Benoit E; Besse S; Boukraa A
    Xenobiotica; 1991 Feb; 21(2):217-21. PubMed ID: 2058177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous determination of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma.
    Batzias GC; Delis GA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):267-74. PubMed ID: 15135100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis.
    Wen H; Zhang HW; Muhmut M; Zou PF; New RR; Craig PS
    Ann Trop Med Parasitol; 1994 Feb; 88(1):49-52. PubMed ID: 8192515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albendazole: new indication. Useful adjunct in hydatid disease.
    Prescrire Int; 2000 Oct; 9(49):139-42. PubMed ID: 11603413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence.
    Mingjie W; Shuhua X; Junjie C; Bin L; Cheng F; Weixia S; Hotez P
    Acta Trop; 2002 Aug; 83(2):177-81. PubMed ID: 12088859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of the efficacy of albendazole treatment in human hydatidosis].
    Rădulescu S; Angelescu N; Horvat T; Lazăr L; Creţu C; Popa L; Filiu P; Ene V; Burcoş T; Ifrim S; Popa G
    Chirurgia (Bucur); 1997; 92(5):331-5. PubMed ID: 9462951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [(EXPERIENCE WITH ALBENDAZOLE TREATMENT IN CHILDREN WITH CYSTIC ECHINOCOCCOSIS)].
    Legonkov YA; Bronshtein AM
    Med Parazitol (Mosk); 2017 Apr; (2):9-13. PubMed ID: 30721596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.